SouthernWorldwide.com – Scientists are increasingly pointing to the gut as a key factor in determining why some individuals develop life-threatening sepsis while others do not.
Researchers from the Korea Research Institute of Bioscience and Biotechnology’s Infectious Disease Research Center have been investigating the stark differences in sepsis outcomes among patients. Their work utilized female mouse models to explore this complex phenomenon.
The study, which was published in the prestigious journal Nature, focused on genetically similar mice that possessed distinct gut microbiomes. These mice were intentionally infected with Acinetobacter baumannii, a highly adaptable bacterium known for its resilience and its potential to cause sepsis.
The research team meticulously compared groups of mice exhibiting varying survival rates following the infection. They closely examined their gut microbiomes, the presence of bacteria in their blood and organs, and other cellular indicators, as detailed in the study’s press release.
Interestingly, despite being genetically alike, the mice that were more susceptible to severe outcomes showed a higher concentration of Muribaculaceae bacteria within their gut. In one specific comparison, these bacteria constituted approximately 28% of the microbiome in poorly surviving mice, contrasting sharply with just 0.15% in those that survived better.
Mice with poorer survival rates exhibited an early and pronounced inflammatory response. This heightened inflammation subsequently led to a greater presence of bacteria in their blood, lungs, and spleen. The researchers suggest this indicates that the gut microbiome can prime the immune system to become overly reactive.
Furthermore, within the gut microbiome of the less resilient mice, researchers identified a particular bacterial strain, Sangeribacter muris KT1-3, as being particularly prominent. When mice that typically had high survival rates were housed with mice carrying this KTI-3 strain, their survival rates plummeted to a mere 10%.
This specific bacterial strain also appeared to exacerbate inflammation during certain types of infections, thereby increasing the severity of sepsis.
These findings strongly suggest that the composition of the gut microbiome can act as an early signal, influencing how the immune system will respond even before an infection takes hold.
Dr. Andrew Fleming, section chief of Infectious Diseases & Immunology at NYU Langone Hospital, Brooklyn, noted that the connection between gut bacteria, bacterial toxins, and their release into the bloodstream during sepsis has been a known factor for many years. Dr. Fleming was not involved in the current study.
This process, he explained, can intensify the inflammatory response to the initial infection.
In cases of septic shock, this mechanism becomes particularly critical. During septic shock, the intestinal wall’s permeability increases, allowing for the translocation, or leaking, of bacterial products into the bloodstream.
Dr. Fleming described the interactions between the gut microbiome and the immune system as intricate and highly variable from one individual to another.
However, he emphasized that there is growing evidence supporting the idea that a diverse and healthy gut microbiome—the complex community of bacteria residing in our intestines—offers a protective effect against severe sepsis.
Conversely, a dysregulated microbiome, such as one significantly altered by antibiotic use, can impair or worsen the immune system’s capacity to combat sepsis.
Scientists are increasingly conceptualizing the gut microbiome as a “living organ,” akin to the heart, kidneys, or liver, all of which perform multiple vital functions to maintain bodily health.
An unhealthy microbiome, Dr. Fleming added, can have detrimental consequences across a spectrum of health issues, including how the body mounts a defense against infections.
He pointed out that, compared to other organs, readily available tests in a clinical setting to measure the health of our microbiome are still limited. Nevertheless, this should not deter us from considering the importance of our gut microbiome and actively working to keep it healthy.
The use of antibiotics, Dr. Fleming highlighted, can have profound and long-lasting impacts on the microbiome. The Centers for Disease Control and Prevention (CDC) reports that up to 80% of adults in the U.S. are prescribed an antibiotic annually, with an estimated 30% of these prescriptions being unnecessary.
Consequently, there is a pressing need to adopt a more critical approach to antibiotic use and overuse, both to preserve our gut health and to combat the escalating problem of antibiotic resistance.
Dr. Fleming views the study’s findings as an “intriguing starting point” for further investigation, while also acknowledging certain key limitations.
He clarified that Sangeribacter muris is not typically found in humans, meaning the precise mechanism by which this bacterial strain exacerbates sepsis, as demonstrated in the study, cannot be directly applied to human populations.
Well-designed clinical trials will be essential to explore how similar gut microbiome effects might manifest in human sepsis cases.
Despite these limitations, Dr. Fleming expressed support for the hypothesis that maintaining a healthy gut microbiome can contribute to a well-regulated immune system and potentially reduce the risk of developing severe sepsis.
